Parity Group PLC
07 November 2003
Fax letter to Parity Group plc
Dated: 6 November 2003
From: Unicorn Asset Management Limited
SALE OF SHARES - SECTION 198-210 COMPANIES ACT 1985 AS AMENDED
As required by the above Act, I am writing to advise you that following the sale
of 1,000,000 5p ordinary shares by Eaglet Investment Trust plc on 04 November
2003, Unicorn Asset Management Limited is interested in 24,372,162 ordinary
shares of 5p each which represents 15.83% of this class of capital.
Fund Holdings after transaction
Eaglet Investment Trust plc 22,932,162
(held HSBC Global Nominees Ltd a/c Eaglet)
Unicorn Investment Funds - Unicorn UK Smaller Companies 1,440,000
(Held HSBC Global Nominees Ltd a/c - Unicorn UK Smaller
Companies)
Total 24,372,162
This interest arises purely from the status of Unicorn Asset Management Limited
as investment manager to the above companies. Unicorn Asset Management Limited
is not the beneficial owner of the shares and should not be identified as such.
For and on behalf of Unicorn Asset Management Limited
Philip John
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.